| View |
|
DRP-10874-03
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Lamsul
|
1 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin – Beta-Lactamase Inhibitor Combination)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
06 August 2024
|
10 December 2026
|
| View |
|
DRP-1093-10
|
Co-Amoxiclav
|
Orcomox-S
|
156.25 mg per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
14 October 2028
|
| View |
|
DRP-11525-02
|
Levofloxacin
|
Floxamed
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
31 March 2027
|
| View |
|
DRP-11632-02
|
Levodropropizine
|
Levobright
|
30 mg / 5ml
|
|
Cough Suppresant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
22 October 2026
|
| View |
|
DRP-11635-05
|
Amlodipine (as besilate)
|
Pulsalife 5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
04 April 2027
|
| View |
|
DRP-11661-08
|
Propofol
|
Zipropol
|
10 mg/mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
03 August 2024
|
07 April 2027
|
| View |
|
DRP-11789-10
|
Dapagliflozin
|
Dapafoz
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 August 2024
|
29 April 2027
|
| View |
|
DRP-11798-01
|
Betahistine Hydrochloride
|
Verahit
|
16 mg
|
Tablet
|
Antivertigo
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
29 April 2027
|
| View |
|
DRP-11801-08
|
Cefuroxime (as sodium)
|
Congloxime-750
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
06 August 2024
|
29 April 2027
|
| View |
|
DRP-11851-10
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Mixcemont
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
25 July 2024
|
10 May 2027
|
| View |
|
DRP-11939-03
|
Metformin hydrochloride
|
Maximet
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (Biguanide)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
20 May 2027
|
| View |
|
DRP-12190-04
|
Loperamide Hydrochloride
|
Lopelife
|
2 mg
|
Capsule
|
Antidiarrheal
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
03 August 2024
|
28 June 2027
|
| View |
|
DRP-12225-04
|
Atorvastatin (as Calcium Trihydrate)
|
Lifetor 10
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
ACME Formulations Pvt. Ltd
|
|
CLIDP Conversion
|
03 August 2024
|
12 July 2027
|
| View |
|
DRP-12328-03
|
Metformin hydrochloride + Sitagliptin (as phosphate)
|
Retaglimet
|
1 g/50 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
15 July 2027
|
| View |
|
DRP-12415-01
|
Citicoline (as sodium)
|
Neuboost
|
1 g
|
Film-Coated Tablet
|
Psychostimulant and Nootropic
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 August 2024
|
03 August 2027
|
| View |
|
DRP-12601-11
|
Febuxostat
|
Surixtat
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
06 August 2024
|
14 September 2027
|
| View |
|
DRP-12623-03
|
Trimetazidine Hydrochloride
|
Trimetech
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 August 2024
|
29 November 2026
|
| View |
|
DRP-12647-01
|
Multivitamins + Minerals
|
Zeldiron
|
(see reverse for formulation)
|
Hard Gelatin Capsule
|
Vitamin/Mineral
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 August 2024
|
20 September 2027
|
| View |
|
DRP-12864-04
|
Glimepiride
|
Diabelife
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
18 October 2027
|
| View |
|
DRP-12992-01
|
Mupirocin
|
Mupifer-C
|
20 mg/g (2% w/w)
|
Topical Cream
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
04 August 2024
|
14 November 2027
|